Living in the liver: hepatic infections
The liver has vital metabolic and clearance functions that involve the uptake of nutrients,
waste products and pathogens from the blood. In addition, its unique immunoregulatory …
waste products and pathogens from the blood. In addition, its unique immunoregulatory …
[PDF][PDF] Reactivation of hepatitis B
JH Hoofnagle - Hepatology, 2009 - Wiley Online Library
Reactivation of hepatitis B refers to the abrupt increase in hepatitis B virus (HBV) replication
in a patient with inactive or resolved hepatitis B. Reactivation can occur spontaneously, but …
in a patient with inactive or resolved hepatitis B. Reactivation can occur spontaneously, but …
[HTML][HTML] Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
Background Rituximab has been associated with hepatitis B virus reactivation (HBV-R).
However, the characteristics and scope of this association remain largely undefined …
However, the characteristics and scope of this association remain largely undefined …
[HTML][HTML] Liver immunology
The liver is the largest organ in the body and is generally regarded by non-immunologists as
not having lymphoid function. However, such is far from accurate. This review highlights the …
not having lymphoid function. However, such is far from accurate. This review highlights the …
Infectious complications of biological and small molecule targeted immunomodulatory therapies
The past 2 decades have seen a revolution in our approach to therapeutic
immunosuppression. We have moved from relying on broadly active traditional medications …
immunosuppression. We have moved from relying on broadly active traditional medications …
Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy
S Kusumoto, L Arcaini, X Hong, J Jin… - Blood, The Journal …, 2019 - ashpublications.org
Risk of hepatitis B virus (HBV) reactivation was assessed in B-cell non-Hodgkin lymphoma
(NHL) patients with resolved HBV infection (hepatitis B surface antigen negative, hepatitis B …
(NHL) patients with resolved HBV infection (hepatitis B surface antigen negative, hepatitis B …
[HTML][HTML] Does rituximab increase the incidence of infectious complications? A narrative review
Background: Rituximab has increasingly been used for the treatment of hematological
malignancies and autoimmune diseases, and its efficacy and safety are well established …
malignancies and autoimmune diseases, and its efficacy and safety are well established …
Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients
SN Pei, CH Chen, CM Lee, MC Wang, MC Ma… - Annals of …, 2010 - Springer
Hepatitis B virus (HBV) reactivation is a well-known complication of lymphoma treatment in
the pre-rituximab era. This complication has not been as well studied, however, since …
the pre-rituximab era. This complication has not been as well studied, however, since …
Autoimmunity associated with immunotherapy of cancer
SM Amos, CPM Duong, JA Westwood… - Blood, The Journal …, 2011 - ashpublications.org
In this age of promise of new therapies for cancer, immunotherapy is emerging as an
exciting treatment option for patients. Vaccines and cytokines are being tested extensively in …
exciting treatment option for patients. Vaccines and cytokines are being tested extensively in …
Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: a meta-analysis
HJ Dong, LN Ni, GF Sheng, HL Song, JZ Xu… - Journal of Clinical …, 2013 - Elsevier
BACKGROUND: The addition of Rituximab to standard chemotherapy (C) has been reported
to improve the end of treatment outcome in non-Hodgkin lymphoma (NHL) patients …
to improve the end of treatment outcome in non-Hodgkin lymphoma (NHL) patients …